Flag of the European Union EU Clinical Trials Register Help

Clinical trials for COMP

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    184 result(s) found for: COMP. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2007-005613-19 Sponsor Protocol Number: R-COMP 14 Start Date*: 2007-04-27
    Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE
    Full Title: R-COMP 14 in elderly patients with high grade non-Hodgkin lymphoma
    Medical condition: Elderly patients with B non-Hodgkin lymphoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10025320 Lymphomas non-Hodgkin's B-cell HLGT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005140-16 Sponsor Protocol Number: KAI-9803-004 Start Date*: 2009-06-02
    Sponsor Name:KAI Pharmaceuticals, Inc
    Full Title: Inhibition of δ-PROTEin kinase C for the reducTION of infarct size in Acute Myocardial Infarction (PROTECTION AMI)
    Medical condition: Acute Myocardial Infarction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000891 Acute myocardial infarction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) BE (Completed) SE (Completed) FI (Completed) IT (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-018112-26 Sponsor Protocol Number: DR-CR-GEN01S02 Start Date*: 2010-11-04
    Sponsor Name:Weleda AG
    Full Title: Efficacy and tolerability of Citrus/Cydonia comp.® 1% solution for injection in patients with grass pollen seasonal allergic rhinitis: A randomised, double-blind, placebo-controlled clinical trial
    Medical condition: Grass pollen allergic rhinitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-006390-24 Sponsor Protocol Number: DISCI-Studie Start Date*: 2007-03-23
    Sponsor Name:WALA Heilmittel GmbH
    Full Title: Prospektive, randomized, controlled, multicentre, partly double blind study to compare Disci/Rhus toxicodendron comp., placebo and waiting list in patients with chronic low back pain.
    Medical condition: chronic low back pain (chronic local or pseudoradiculaere low back pain due to e.g. degenerative basic illness).
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002927-27 Sponsor Protocol Number: OY20167 Start Date*: 2016-08-15
    Sponsor Name:University of Oulu, Department of Pediatrics, PEDEGO-Research unit
    Full Title: Effect of antimicrobial treament of acute otitis media on the intestinal micobiome in children: A randomized controlled trial
    Medical condition:
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2020-001348-25 Sponsor Protocol Number: COMP004 Start Date*: 2020-07-08
    Sponsor Name:COMPASS Pathways, Ltd
    Full Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
    Medical condition: Treatment-Resistant Depression (P-TRD)
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004873 10025463 Major depressive disorder, single episode LLT
    21.1 100000004873 10025454 Major depressive disorder, recurrent episode LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PT (Completed) CZ (Completed) DK (Completed) NL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001199-37 Sponsor Protocol Number: GOTEL-2003 Start Date*: 2004-08-19
    Sponsor Name:(GOTEL) Grupo Oncológico para el tratamiento y estudio de los linfomas
    Full Title: A Phase II, Single Arm, Open label Study of Cyclophosphamide, Vincristine, Liposomal Doxorubicine (Myocet™) and Prednisone plus Rituximab in Fortnightly Regimen (R-COMP-14), as First Line of thera...
    Medical condition: Dose-dense modified R-CHOP regimen (R-COMP) in patients with aggressive NHL.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-003666-26 Sponsor Protocol Number: AREM07 Start Date*: 2010-01-12
    Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE)
    Full Title: A double-blind, randomized trial of ARNICA comp.-Heel treatment in patients undergoing hemorrhoidectomy in day surgery: evaluation of postoperative pain
    Medical condition: patients undergoing hemorrhoidectomy in day surgery
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042613 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-007749-29 Sponsor Protocol Number: UKCRN4499 Start Date*: 2009-09-02
    Sponsor Name:R&D Department, [...]
    1. R&D Department,
    2. Cambridge Clinical Trials Unit
    Full Title: Monotherapy vs Dual Therapy for Initial Treatment for hypertension
    Medical condition: Resistant Hypertension
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10020772 Hypertension PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-001065-17 Sponsor Protocol Number: GEL-R-COMP-2013 Start Date*: 2013-08-01
    Sponsor Name:Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO)
    Full Title: Phase II, randomised, multicentre study with two treatment arms (R-COMP versus R-CHOP) in newly diagnosed elderly patients (?60 years) with non-localised diffuse large B-cell lymphoma (DLBCL)/folli...
    Medical condition: Non-localised diffuse large B-cell lymphoma/Follicular lymphoma grade IIIb
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2012-001665-33 Sponsor Protocol Number: Koti Start Date*: 2012-06-14
    Sponsor Name:Päijät-Häme Central Hospital
    Full Title:
    Medical condition: Otitis media acuta
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-004970-24 Sponsor Protocol Number: NHL-14 Start Date*: 2008-01-17
    Sponsor Name:AGMT - Arbeitsgemeinschaft Medikamentöse Tumortherapie Gemeinnützige GmbH
    Full Title: Multizentrische Studie über die Cardiotoxizität von R-CHOP (Rituximab, Cyclophosphamid, Doxorubicin, Vincristin und Prednisolon) v. R-COMP (Rituximab, Cyclophosphamid, liposomalem Doxorubicin, Vinc...
    Medical condition: Diffus großzelliges B-Zell Lymphom
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012819 Diffuse large B-cell lymphomas HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2013-004604-19 Sponsor Protocol Number: CAR-ERA Start Date*: 2014-08-06
    Sponsor Name:Heinrich-Heine-Universität Düsseldorf
    Full Title: Delayed Gadolinium-enhanced Magnetic resonance Imaging (MRI) of Cartilage - A pilot study to measure the effect of Adalimumab plus Methotrexat (MTX) versus Placebo plus MTX on cartilage in early rh...
    Medical condition: patients with early progressive rheumatoid arthritis
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004859 10066578 Progression of rheumatoid arthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-000509-40 Sponsor Protocol Number: GEB-MET-2006-01 Start Date*: 2006-06-02
    Sponsor Name:Gebro Pharma
    Full Title: Estudio piloto unicéntrico, aleatorizado, abierto, de grupos paralelos, controlado con metotrexato oral, para evaluar la eficacia y seguridad del tratamiento de la psoriasis en placas con metotrexa...
    Medical condition: Psoriasis vulgar moderada o grave del tipo en placas
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2021-002210-13 Sponsor Protocol Number: STARC210421 Start Date*: 2022-01-17
    Sponsor Name:The department of cardiac, thoracic and vascular surgery - Odense University Hospital
    Full Title: Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors
    Medical condition: Trial 2: Condition under investigation: Postoperative atrial fibrillation after surgical aortic valve replacement. In patients no prior usage of statins: 14 days prior surgery to 30days after - Ato...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10003660 Atrial fibrillation and flutter LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-012143-42 Sponsor Protocol Number: HEART01 Start Date*: 2009-10-08
    Sponsor Name:IIL INTERGRUPPO ITALIANO LINFOMI ONLUS
    Full Title: Multicenter study of phase II with Rituximab, cyclophosphamide, doxorubicin liposomal (Myocet), vincristine, Prednisone, (R-COMP) in diffuse Non-Hodgkin`s lymphoma, large B cells of the cardiopath...
    Medical condition: Diffuse Non-Hodgkin`s lymphoma, large B cells of the cardiopathic patient
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012818 PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-024448-13 Sponsor Protocol Number: 010884 Start Date*: 2011-02-18
    Sponsor Name:Netherlands Heart Foundation
    Full Title: Effects of low-dose aspirin taken at bedtime on blood pressure of subjects with who use aspirin for prevention of recurrent cardiovascular events: the Aspirin In Reduction of Tension II (ASPIRETENS...
    Medical condition: The medical condition to be investigated is hypertension
    Disease: Version SOC Term Classification Code Term Level
    12.1 10020772 Hypertension PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002222-30 Sponsor Protocol Number: 06-015 Start Date*: 2007-08-28
    Sponsor Name:Jazz Pharmaceuticals Inc.
    Full Title: Single- and Multiple-Dose Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem®) in Subjects with Moderate to Severe Essential Tremor
    Medical condition: Patients undergoing moderate or severe classic essential tremor
    Disease: Version SOC Term Classification Code Term Level
    9.1 10032297 Other nervous system complications LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021987-13 Sponsor Protocol Number: NL29900.04 Start Date*: 2010-10-15
    Sponsor Name:University Medical Center Groningen
    Full Title: Renal Hemodynamic Effects of ALiskiren (rasilez) in comparison to ramipril (Tritrace) in patients with overweigHt/obeSiTy and UntreateD hYpertension: The renal HEALTH-STUDY
    Medical condition: Glomerular hypertension
    Disease: Version SOC Term Classification Code Term Level
    12.1 10020772 Hypertension LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000310-36 Sponsor Protocol Number: 2542 Start Date*: 2007-04-05
    Sponsor Name:Radboud University Medical Center Njmegen
    Full Title: Does statin therapy reduce sympathoexcitation in hypertension
    Medical condition: hypertension and sympathoexcitation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020782 Hypertension NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 14:18:13 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA